Who Owns Beta Bionics Stock?
NASDAQ: BBNXHealth CareMedical/Dental InstrumentsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Ownership breakdown
- Held by institutions
- 112.87%
- Institutions (% of float)
- 113.80%
- Held by insiders
- 0.82%
- Institutional holders
- 192
- Institutions 99.2%
- Insiders 0.8%
- Public and other 0.0%
Who owns Beta Bionics stock?
Institutional investors own about 112.9% of Beta Bionics's shares, spread across 192 institutions that file 13F reports. That level of institutional ownership is high, typical of large, widely followed companies. Insiders, including executives, directors and large founding shareholders, hold 0.82% of BBNX.
The largest institutional holders are Eventide Asset Management LLC (13.90%), Soleus Capital Management, L.P. (9.77%) and Morgan Stanley (9.48%). Together, the top 10 institutions control 67.6% of shares outstanding. In their latest filings, 5 of the top 10 institutions increased their BBNX positions and 3 reduced them.
Summary generated from market data by MetaCap's automated system. Methodology
Top institutional holders of BBNX
| Institution | Shares | % Held | Change |
|---|---|---|---|
| Eventide Asset Management LLC | 6.25M | 13.90% | +5.2% |
| Soleus Capital Management, L.P. | 4.39M | 9.77% | +0.9% |
| Morgan Stanley | 4.27M | 9.48% | +0.9% |
| Sands Capital Alternatives, LLC | 3.71M | 8.24% | 0.0% |
| Blackrock Inc. | 3.34M | 7.42% | +9.9% |
| Point72 Asset Management, L.P. | 2.25M | 5.01% | -10.7% |
| Vanguard Capital Management LLC | 1.78M | 3.96% | +3.1% |
| Vestal Point Capital, LP | 1.60M | 3.56% | -27.6% |
| RTW Investments LP | 1.50M | 3.33% | -25.0% |
| Deerfield Management Company, L.P | 1.32M | 2.94% | 0.0% |
% held is the share of total shares outstanding. Change is the percentage change in the position since the holder's previous 13F filing.
Top mutual fund and ETF holders of BBNX
| Fund | Shares | % Held |
|---|---|---|
| MUTUAL FUND SERIES TRUST-Eventide Gilead Fund | 3.98M | 8.86% |
| MUTUAL FUND SERIES TRUST-Eventide Healthcare & Life Sciences Fund | 2.05M | 4.56% |
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 1.27M | 2.83% |
| iShares Trust-iShares Russell 2000 ETF | 1.05M | 2.33% |
| Bruce Fund, Inc.-BRUCE FUND | 665.70K | 1.48% |
| VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund | 469.62K | 1.04% |
| Fidelity Salem Street Trust-Fidelity Small Cap Index Fund | 445.44K | 0.99% |
| iShares Trust-iShares Russell 2000 Value ETF | 374.40K | 0.83% |
| JPMorgan Trust II-JPMorgan Small Cap Value Fund | 221.45K | 0.49% |
| Fidelity Concord Street Trust-Fidelity Extended Market Index Fund | 202.41K | 0.45% |
Frequently asked questions
Who is the largest shareholder of Beta Bionics?
Eventide Asset Management LLC is the largest institutional shareholder of BBNX, owning 13.90% of shares outstanding (6.25M shares) as of its latest 13F filing.
What percentage of Beta Bionics is owned by institutions?
Institutions own about 112.9% of BBNX shares and 113.8% of the public float.
How much of Beta Bionics do insiders own?
Insiders, such as officers and directors, own about 0.82% of BBNX shares outstanding.
Where does institutional ownership data come from?
Investment managers with more than $100 million in US equities must file Form 13F with the SEC within 45 days of each quarter-end. Holdings are therefore up to about 4.5 months old when published.